Revance Therapeutics Is Maintained at Neutral by Mizuho

Dow JonesDec 10 21:19 · Ratings

Revance Therapeutics Analyst Ratings

BenzingaDec 10 21:08 · Ratings

Express News | Revance Therapeutics Inc : Mizuho Cuts Target Price to $3.10 From $6.66

BreakingsDec 10 20:03

Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating, Announces Target Price $6.66

Futu NewsDec 10 14:32 · Ratings

Analysts Conflicted on These Healthcare Names: Revance Therapeutics (RVNC), Syndax Pharmaceuticals (SNDX) and Align Tech (ALGN)

TipRanksDec 10 14:31 · Ratings

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaDec 10 05:05